CSPC Pharmaceutical Group Ltd (CHJTF)
0.85
0.00 (0.00%)
USD |
OTCM |
May 21, 16:00
CSPC Pharmaceutical Group Shareholders Equity (Quarterly): 4.684B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.684B |
| June 30, 2023 | 4.387B |
| June 30, 2023 | 4.387B |
| December 31, 2022 | 4.377B |
| June 30, 2022 | 4.184B |
| December 31, 2021 | 4.077B |
| June 30, 2021 | 3.790B |
| June 30, 2021 | 3.790B |
| December 31, 2020 | 3.418B |
| June 30, 2020 | 2.816B |
| June 30, 2020 | 2.816B |
| December 31, 2019 | 2.639B |
| June 30, 2019 | 2.392B |
| June 30, 2019 | 2.392B |
| December 31, 2018 | 2.188B |
| June 30, 2018 | 2.053B |
| June 30, 2018 | 2.053B |
| December 31, 2017 | 1.959B |
| June 30, 2017 | 1.416B |
| June 30, 2017 | 1.416B |
| Date | Value |
|---|---|
| December 31, 2016 | 1.303B |
| June 30, 2016 | 1.153B |
| June 30, 2016 | 1.153B |
| December 31, 2015 | 1.127B |
| June 30, 2015 | 1.072B |
| June 30, 2015 | 1.072B |
| December 31, 2014 | 1.041B |
| June 30, 2014 | 957.27M |
| June 30, 2014 | 957.27M |
| December 31, 2013 | 960.94M |
| June 30, 2013 | 882.56M |
| June 30, 2013 | 882.56M |
| December 31, 2012 | 849.69M |
| June 30, 2012 | 732.10M |
| December 31, 2011 | 121.40M |
| June 30, 2011 | 741.86M |
| December 31, 2010 | 84.62M |
| June 30, 2010 | 671.60M |
| December 31, 2009 | 665.16M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
2.392B
Minimum
Jun 2019
4.684B
Maximum
Dec 2023
3.582B
Average
3.790B
Median
Jun 2021
Shareholders Equity (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 8.709B |
| CASI Pharmaceuticals Inc | 15.47M |
| Zai Lab Ltd | 762.17M |
| Gracell Biotechnologies Inc (DELISTED) | 222.18M |
| Adagene Inc | 70.56M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.529B |
| Total Liabilities (Quarterly) | 1.589B |
| Debt to Equity Ratio | 0.0136 |
| Current Ratio | 2.626 |
| Net Debt Paydown Yield | -0.13% |